GSK ap­points Kevin Sin as SVP, Global Re­search Head

BioSpectrum (Asia) - - PEOPLE NEWS -

Glax­o­SmithK­line (GSK) has an­nounced the ap­point­ment of Kevin Sin as Se­nior Vice Pres­i­dent and Head of World­wide Busi­ness Devel­op­ment for Phar­ma­ceu­ti­cals Re­search & Devel­op­ment. In this po­si­tion, Kevin will play a crit­i­cal role in strength­en­ing GSK’s phar­ma­ceu­ti­cal pipe­line and iden­ti­fy­ing en­abling tech­nolo­gies to en­hance de­liv­ery of in­no­va­tive new medicines for pa­tients. Kevin will join GSK in July 2018 from Ge­nen­tech, where he is cur­rently Vice Pres­i­dent and Global Head of On­col­ogy Busi­ness Devel­op­ment, re­spon­si­ble for part­ner­ing, ac­qui­si­tion and li­cens­ing ac­tiv­i­ties for novel on­col­ogy ther­a­peu­tics.

He has worked within the phar­ma­ceu­ti­cal and life sciences in­dus­try for over 20 years in roles span­ning busi­ness devel­op­ment, le­gal and re­search. Prior to join­ing Ge­nen­tech in 2006, Kevin was an at­tor­ney ad­vis­ing pri­vate and pub­lic life sciences com­pa­nies on busi­ness devel­op­ment and strate­gic part­ner­ing trans­ac­tions. He be­gan his ca­reer as a sci­en­tist.

Kevin holds a B.A. in Molec­u­lar and Cell Bi­ol­ogy from the Uni­ver­sity of Cal­i­for­nia, Berke­ley and a post grad­u­ate de­gree (Juris Doc­tor) from the Uni­ver­sity of San Fran­cisco School of Law.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.